Journal of Medicinal Chemistry p. 5284 - 5297 (2004)
Update date:2022-08-04
Topics:
Eldrup, Anne B.
Prhavc, Marija
Brooks, Jennifer
Bhat, Balkrishen
Prakash, Thazha P.
Song, Quanlai
Bera, Sanjib
Bhat, Neelima
Dande, Prasad
Cook, P. Dan
Bennett, C. Frank
Carroll, Steven S.
Ball, Richard G.
Bosserman, Michele
Burlein, Christine
Colwell, Lawrence F.
Fay, John F.
Flores, Osvaldo A.
Getty, Krista
LaFemina, Robert L.
Leone, Joseph
MacCoss, Malcolm
McMasters, Daniel R.
Tomassini, Joanne E.
Von Langen, Derek
Wolanski, Bohdan
Olsen, David B.
Hepatitis C virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified 2′-C-methyladenosine and 2′-C-methylguanosine as potent nucleoside inhibitors of HCV RNA replication in vitro. However, both of these compounds suffered from significant limitations. 2′-C-Methyladenosine was found to be susceptible to enzymatic conversions by adenosine deaminase and purine nucleoside phosphorylase, and it displayed limited oral bioavailability in the rat. 2′-C-Methylguanosine, on the other hand, was neither efficiently taken up in cells nor phosphorylated well. As part of an attempt to address these limitations, we now report upon the synthesis and evaluation of a series of heterobase-modified 2′-C-methyl ribonucleosides. The structure-activity relationship within this series of nucleosides reveals 4-amino-7-(2-C-methyl- β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine and 4-amino-5-fluoro-7-(2-C- methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine as potent and noncytotoxic inhibitors of HCV RNA replication. Both 4-amino-7-(2-C-methyl- β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine and 4-amino-5-fluoro-7-(2-C- methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine display improved enzymatic stability profiles as compared to that of 2′-C-methyladenosine. Consistent with these observations, the most potent compound, 4-amino-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine ribonucleoside, is orally bioavailable in the rat. Together, the potency of the 2′-C-methyl-4-amino- pyrrolo[2,3-d]pyrimidine ribonucleosides and their improved pharmacokinetic properties relative to that of 2′-C-methyladenosine suggests that this class of compounds may have clinical utility.
View Morewebsite:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
HANGZHOU EVC CHEMICAL CO.,LTD.(expird)
Contact:+86-571-88296056
Address:Room#3001,Zhejiang Chemical Market,No.10,Road Shenban,Hangzhou,Zhejiang,China
Contact:86-571-61063068
Address:LINAN
Chemtrade International ( China )
Contact:+86-532-86893005
Address:Rm 2-501, Huaxia Zonghe Building, No. 410 JInggangshan Road, Huangdao
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Doi:10.1081/SCC-120021043
(2003)Doi:10.1016/0040-4039(76)80104-9
(1976)Doi:10.1021/jm030230z
(2003)Doi:10.1016/S0022-328X(00)94080-4
(1979)Doi:10.1016/S0957-4166(97)00284-X
(1997)Doi:10.1016/j.tetlet.2003.08.029
(2003)